Unexpectedly high but still asymptomatic iron overload in a patient with pyruvate kinase deficiency

Hematology Journal

Volumn 5, Issue 6, 2004, Pages 543-545

  Andersen, Frank D ^a   d'Amore, Francesco ^a   Nielsen, Finn Cilius ^b   van Solinge, Wouter ^c   Jensen, Finn ^a   Jensen, Peter D ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Hemolytic anemia; Iron overload; Pyruvate kinase deficiency

Indexed keywords

DEFEROXAMINE; GLUCOCORTICOID; IRON; PYRUVATE KINASE;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CONCENTRATION (PARAMETERS); ENZYME DEFICIENCY; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; INTESTINE ABSORPTION; IRON ABSORPTION; IRON CHELATION; IRON OVERLOAD; LIVER LEVEL; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; RISK ASSESSMENT; SPLENECTOMY; SPLENOMEGALY; SYMPTOMATOLOGY;

ADULT; ANEMIA, HEMOLYTIC, CONGENITAL; FERRITINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTESTINAL ABSORPTION; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; PYRUVATE KINASE; PYRUVATE METABOLISM, INBORN ERRORS; RISK FACTORS; SPLENECTOMY;

EID: 11044229097     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200556     Document Type: Article

References (18)

1. Fairbanks VS, Baldus WP. Haemolytic anaemias. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds). Williams Hematology, Vol 532. McGraw-Hill: New York, 1995.
2. Pootrakul P, Kitcharoen K, Yansukon P, Wasi P, Fucharoen S, Charoenlarp P et al. The effect of erythroid hyperplasia on iron balance. Blood 1988; 71: 1124-1129.
3. Zanella A, Berzuini A, Colombo MB, Guffanti A, Lecchi L, Poli F et al. Iron status in red cell pyruvate kinase deficiency: study of Italian cases. Br J Haematol 1993; 83: 485-490.
4. Zanella A, Bianchi P, Iurlo A, Boschetti C, Taioli E, Vercellati C et al. Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of italian cases. Blood Cells Mol Dis 2001; 27: 653-661.
5. Brittenham GM, Sheth S, Allen CJ, Farrell DE. Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. Semin Hematol 2001; 38: 37-56.
6. Pippard M. Measurement of iron status. Prog Clin Biol Res 1989; 309: 705-713.
7. van Solinge WW, Kraaijenhagen RJ, Rijksen G, van Wijk R, Stoffer BB, Gajhede M et al. Molecular modelling of human red blood cell pyruvate kinase: structural implications of a novel G1091 to A mutation causing severe nonspherocytic hemolytic anemia. Blood 1997; 90: 4987-4995.
8. Jensen PD, Jensen FT, Christensen T, Ellegaard J. Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol 1994; 87: 171-184.
9. Olivieri NF, Brittenham GM. Iron-chelation therapy and the treatment of thalassemia. Blood 1997; 89: 739-761.
10. Porter JB. Practical management of iron overload. Br J Haematol 2001; 115: 239-252.
11. Jensen PD, Jensen FT, Christensen T, Nielsen JL, Ellegaard J. Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias. Blood 2003; 101: 91-96.
12. Marshall SR, Saunders PW, Hamilton PJ, Taylor PR. The dangers of iron overload in pyruvate kinase deficiency. Br J Haematol 2003; 120: 1090-1091.
13. Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997; 61: 762-764.
14. Borgna-Pignatti C, Solinas A, Bombieri C, Micciolo R, Gamberini MR, De Stefano P et al. The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated. Br J Haematol 1998; 103: 813-816.
15. Risdon RA, Barry M, Flynn DM. Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol 1975; 116: 83-95.
16. Parkin JD, Rush B, De Groot RJ, Budd RS. Iron absorption after splenectomy in hereditary spherocytosis. Aust NZ J Med 1974; 4: 58-61.
17. Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003; 101: 4632-4639.
18. Pootrakul P, Vongsmasa V, La-ongpanich P, Wasi P. Serum ferritin levels in thalassemias and the effect of splenectomy. Acta Haematol 1981; 66: 244-250.